Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
Achieve Life Sciences
AstraZeneca
Bristol-Myers Squibb
Travera Inc
Sandoz
IO Biotech
Novartis
Amgen
AstraZeneca
Novartis
Pfizer
Daiichi Sankyo
NovoCure Ltd.
Dragonfly Therapeutics
Dragonfly Therapeutics
Dragonfly Therapeutics
Merck Sharp & Dohme LLC
Seagen Inc.
Merck Sharp & Dohme LLC
Ono Pharmaceutical Co. Ltd
Pfizer
AstraZeneca
NeoImmuneTech
Jiangsu HengRui Medicine Co., Ltd.
Akeso
Regeneron Pharmaceuticals
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Incyte Corporation
BeOne Medicines
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
Eli Lilly and Company
Boehringer Ingelheim
AstraZeneca
Genentech, Inc.
Exelixis
Novartis
Jacobio Pharmaceuticals Co., Ltd.
AstraZeneca
Bristol-Myers Squibb
Bristol-Myers Squibb
Revolution Medicines, Inc.
BeOne Medicines
Pharmassist Ltd
Jacobio Pharmaceuticals Co., Ltd.